Spruce Biosciences, Inc. (SPRB)
NASDAQ · Manufacturing · Pharmaceutical preparations
SPRB price, last 12 months
Key stats
- Previous close
- $49.02
- Open
- $49.22
- Day range
- $47.54 – $49.31
- 52-week range
- $7.26 – $240.00
- Volume
- 25.8K
- Avg volume (20 days)
- 110.1K
- Market cap
- $140.0M
Performance
Technicals and fundamentals
About Spruce Biosciences, Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aimed at addressing diseases with unmet medical needs and limited or no approved therapies. Its product candidate, TA-ERT for the treatment of Mucopolysaccharidosis Type IIIB (MPS IIIB), is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) intended as an enzyme replacement therapy for patients who lack rhNAGLU enzyme activity. TA-ERT is designed to restore rhNAGLU enzyme activity in the central nervous system following intracerebroventricular injection and promote clearance of heparan sulfate in the brain.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $140.0M